Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report)’s stock price was up 5.2% on Monday . The stock traded as high as $20.70 and last traded at $20.48. Approximately 105,677 shares traded hands during trading, an increase of 345% from the average daily volume of 23,769 shares. The stock had previously closed at $19.47.
Fortress Biotech Trading Up 5.2%
The company’s fifty day simple moving average is $14.56 and its two-hundred day simple moving average is $11.96.
About Fortress Biotech
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
See Also
- Five stocks we like better than Fortress Biotech
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
